Core Laboratories Statistics
Total Valuation
CLB has a market cap or net worth of $417.45 million. The enterprise value is $558.04 million.
| Market Cap | 417.45M |
| Enterprise Value | 558.04M |
Important Dates
The last earnings date was Wednesday, October 28, 2026, after market close.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Nov 9, 2026 |
Share Statistics
CLB has 45.82 million shares outstanding. The number of shares has decreased by -1.68% in one year.
| Current Share Class | 45.82M |
| Shares Outstanding | 45.82M |
| Shares Change (YoY) | -1.68% |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 103.05% |
| Float | 45.17M |
Valuation Ratios
The trailing PE ratio is 26.95 and the forward PE ratio is 13.20.
| PE Ratio | 26.95 |
| Forward PE | 13.20 |
| PS Ratio | 0.81 |
| Forward PS | 0.80 |
| PB Ratio | 1.50 |
| P/TBV Ratio | 2.52 |
| P/FCF Ratio | 62.62 |
| P/OCF Ratio | 16.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.38, with an EV/FCF ratio of 83.72.
| EV / Earnings | 35.87 |
| EV / Sales | 1.08 |
| EV / EBITDA | 10.38 |
| EV / EBIT | 14.40 |
| EV / FCF | 83.72 |
Financial Position
The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.57.
| Current Ratio | 2.19 |
| Quick Ratio | 1.44 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 2.16 |
| Debt / FCF | 24.30 |
| Interest Coverage | 3.48 |
Financial Efficiency
Return on equity (ROE) is 5.57% and return on invested capital (ROIC) is 5.16%.
| Return on Equity (ROE) | 5.57% |
| Return on Assets (ROA) | 4.09% |
| Return on Invested Capital (ROIC) | 5.16% |
| Return on Capital Employed (ROCE) | 7.90% |
| Weighted Average Cost of Capital (WACC) | 8.77% |
| Revenue Per Employee | $156,587 |
| Profits Per Employee | $4,715 |
| Employee Count | 3,300 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 7.03 |
Taxes
In the past 12 months, CLB has paid $12.17 million in taxes.
| Income Tax | 12.17M |
| Effective Tax Rate | 43.76% |
Stock Price Statistics
The stock price has decreased by -41.00% in the last 52 weeks. The beta is 1.17, so CLB's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -41.00% |
| 50-Day Moving Average | 10.38 |
| 200-Day Moving Average | 13.36 |
| Relative Strength Index (RSI) | 38.01 |
| Average Volume (20 Days) | 679,952 |
Short Selling Information
The latest short interest is 4.95 million, so 10.81% of the outstanding shares have been sold short.
| Short Interest | 4.95M |
| Short Previous Month | 4.87M |
| Short % of Shares Out | 10.81% |
| Short % of Float | 10.97% |
| Short Ratio (days to cover) | 7.00 |
Income Statement
In the last 12 months, CLB had revenue of $516.74 million and earned $15.56 million in profits. Earnings per share was $0.34.
| Revenue | 516.74M |
| Gross Profit | 98.69M |
| Operating Income | 38.76M |
| Pretax Income | 27.80M |
| Net Income | 15.56M |
| EBITDA | 53.74M |
| EBIT | 38.76M |
| Earnings Per Share (EPS) | $0.34 |
Balance Sheet
The company has $21.38 million in cash and $161.97 million in debt, with a net cash position of -$140.60 million or -$3.07 per share.
| Cash & Cash Equivalents | 21.38M |
| Total Debt | 161.97M |
| Net Cash | -140.60M |
| Net Cash Per Share | -$3.07 |
| Equity (Book Value) | 284.09M |
| Book Value Per Share | 6.07 |
| Working Capital | 122.32M |
Cash Flow
In the last 12 months, operating cash flow was $24.69 million and capital expenditures -$18.02 million, giving a free cash flow of $6.67 million.
| Operating Cash Flow | 24.69M |
| Capital Expenditures | -18.02M |
| Depreciation & Amortization | 14.98M |
| Net Borrowing | -2.25M |
| Free Cash Flow | 6.67M |
| FCF Per Share | $0.15 |
Margins
Gross margin is 19.10%, with operating and profit margins of 7.50% and 3.01%.
| Gross Margin | 19.10% |
| Operating Margin | 7.50% |
| Pretax Margin | 5.38% |
| Profit Margin | 3.01% |
| EBITDA Margin | 10.40% |
| EBIT Margin | 7.50% |
| FCF Margin | 1.29% |
Dividends & Yields
This stock pays an annual dividend of $0.04, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 11.83% |
| FCF Payout Ratio | 27.50% |
| Buyback Yield | 1.68% |
| Shareholder Yield | 2.12% |
| Earnings Yield | 3.71% |
| FCF Yield | 1.60% |
Analyst Forecast
The average price target for CLB is $15.00, which is 64.65% higher than the current price. The consensus rating is "Buy".
| Price Target | $15.00 |
| Price Target Difference | 64.65% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 4.91% |
| EPS Growth Forecast (3Y) | 21.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on July 9, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CLB has an Altman Z-Score of 3.08 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.08 |
| Piotroski F-Score | 6 |